Ping-I Hsu

17PUBLICATIONS
36CO-AUTHORS
PharmacogenomicsMedical bacteriologyPreventative health careMedical molecular engineering of nucleic acids and proteinsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 25, 2026
Bismuth-Amoxicillin-Vonoprazan Triple, Amoxicillin-Vonoprazan Dual, and Clarithromycin-Based Triple Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Open-Label, Randomized Trial.

|Mar 28, 2026
Evolution of Amoxicillin-Based Mono-Antibiotic Regimens for Helicobacter pylori Eradication: From Ineffectiveness to Innovation-A Systematic Review.

Chih-An Shih, I-Ting Wu, Deng-Chyang Wu

|Sep 05, 2025
Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II.

Jyh-Ming Liou, Peter Malfertheiner, Tzu-Chan Hong

|Apr 26, 2025
Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Helicobacter pylori Infection: A Systematic Review.

Chih-An Shih, Deng-Chyang Wu, Chang-Bih Shie

|Jan 26, 2024
Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection.

Chien-Lin Chen, I-Ting Wu, Deng-Chyang Wu

|Dec 02, 2022
Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances.

Chih-An Shih, Chang-Bih Shie, Ping-I Hsu

Pageof 3

Frequent Collaborators

6 joint publications

Deng-Chyang Wu

5 joint publications

Seng-Kee Chuah

3 joint publications

Chih-An Shih

2 joint publications

Chien-Lin Chen